Cellebrite reported an initial statement of beneficial ownership by Thomas Hogan, its chief executive officer and a director. Hogan beneficially owned 693,965 ordinary shares. Hogan also held stock options for 1 million ordinary shares with an exercise price of USD 7.39. Hogan also held stock options for 500,000 ordinary shares with an exercise price of USD 7.39.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellebrite DI Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-029873), on March 18, 2026, and is solely responsible for the information contained therein.
Comments